Tuesday, 26 February 2019
Department of Health
National Treatment Purchase Fund Waiting Times
334. To ask the Minister for Health when a person (details supplied) will have surgery; if the procedure will be carried out under the National Treatment Purchase Fund or the EU cross-border directive; if a date will be provided for the surgery; and if he will make a statement on the matter. [9275/19]
Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual.
The National Waiting List Management Policy, a standardised approach to managing scheduled care treatment for in-patient, day case and planned procedures, since January 2014, has been developed to ensure that all administrative, managerial and clinical staff follow an agreed national minimum standard for the management and administration of waiting lists for scheduled care. This policy, which has been adopted by the HSE, sets out the processes that hospitals are to implement to manage waiting lists.
The HSE operates the Cross Border Directive (CBD) in Ireland. Under the terms of the Directive, patients of an EU/EEA Member State who meet the necessary criteria may opt to avail of healthcare provided under the legislation of their Member State of affiliation in another EU/EEA Member State and be reimbursed the lesser of the cost of receiving the treatment abroad, or the cost in their own Member State The HSE provides information for patients on the CBD on its website which can be accessed at and also by phone at 056 7784551.
In relation to the particular queries raised, as this is a service matter, I have asked the HSE to respond to the Deputy directly.